Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × fludarabine × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Multiple Myeloma 14 Myelodysplastic Syndromes 12 Lymphoma 12 Lymphoma, Non-Hodgkin 11 Leukemia, Lymphocytic, Chronic, B-Cell 9 Recurrence 8 Lymphoma, Large B-Cell, Diffuse 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Neoplasms 6 Myeloproliferative Disorders 6 Melanoma 6 Lymphoma, Follicular 6 Lymphoma, B-Cell 6 Hodgkin Disease 6 Pancreatic Neoplasms 5 Ovarian Neoplasms 5 Leukemia, Biphenotypic, Acute 5 Leukemia 5 Hematologic Neoplasms 5 Burkitt Lymphoma 5 Lymphoma, Mantle-Cell 4 Anemia, Refractory, with Excess of Blasts 4 Prostatic Neoplasms 3 Primary Myelofibrosis 3 Neoplasm Metastasis 3 Myelodysplastic-Myeloproliferative Diseases 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Myelomonocytic, Chronic 3

Interventions

pembrolizumab 2 durvalumab 2 Standard of Care 2 Paclitaxel 2 Oxaliplatin 2 Irinotecan 2 Chemoradiotherapy 2 Carboplatin 2 Capecitabine 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 talazoparib 1 sarilumab 1 relugolix 1 regorafenib 1 pexidartinib 1 pertuzumab 1 patritumab 1 olaparib 1 niraparib 1 neratinib 1 ganitumab 1 enzalutamide 1 dostarlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡